In addition to its effects on glioma cells, we also found that silencing of RasGRP3 decreased the migration and invasion of the HF2354 (Fig. 2H) and HF2607 GSCs (Fig. 2I) that express high levels of this protein. This evidence concerns the gene RASGRP3 and central nervous system cancer.